Tohen M, Zarate CA, Hennen J, et al. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry. 2003; 160(12): 2099–107.
Simhandl C, König B, Amann BL. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients. J Clin Psychiatry. 2014; 75(3): 254–62.
Baethge C, Baldessarini RJ, Mathiske-schmidt K, et al. Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients. J Clin Psychiatry. 2005; 66(2): 174–82.
Severus E, Taylor MJ, Sauer C, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. International Journal of Bipolar Disorders. 2014; 2: 15. doi: 10.1186/s40345-014-0015-8.
Van der loos ML, Kölling P, Knoppert-van der klein EA, Nolen WA. [Lamotrigine in the treatment of bipolar disorder, a review]. Tijdschr Psychiatr. 2007; 49(2): 95–103.
Rapoport SI, Basselin M, Kim HW, Rao JS. Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev. 2009; 61(2): 185–209.
Macritchie K, Geddes JR, Scott J, Haslam D, De lima M, Goodwin G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev. 2003; (1): CD004052.
Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry. 2009; 194(1): 4–9.
Severus E, Taylor MJ, Sauer C, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. International Journal of Bipolar Disorders. 2014;2:15. doi: 10.1186/s40345-014-0015-8.
Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry. 2009; 194 (1): 4–9.
Macritchie K, Geddes JR, Scott J, Haslam D, De lima M, Goodwin G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev. 2003; (1): CD004052.
Ushkalova AV, Kostiukova EG, Mosolov SN. [A comparative study of different types of pharmacotherapy in treatment of depressive phase of bipolar II disorder]. Zh Nevrol Psikhiatr Im S S Korsakova. 2015; 115(1 Vypusk 2 Depressiia): 23–30.
Zaretsky AE, Rizvi S, Parikh SV. How well do psychosocial interventions work in bipolar disorder?. Can J Psychiatry. 2007;5 2(1): 14–21.
Frank E, Swartz HA, Mallinger AG, Thase ME, Weaver EV, Kupfer DJ. Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality. J Abnorm Psychol. 1999;108(4): 579–87.
Miklowitz DJ. The Bipolar Disorder Survival Guide, Second Edition, What You and Your Family Need to Know. Guilford Press; 2011.
Braga RJ, Burdick KE, Derosse P, Malhotra AK. Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder. Psychiatry Res. 2012; 200(2–3):242–5.
Steimer T. The biology of fear- and anxiety-related behaviors. Dialogues in Clinical Neuroscience. 2002; 4(3): 231–249.
Ohman A, Lundqvist D, Esteves F. The face in the crowd revisited: a threat advantage with schematic stimuli. J Pers Soc Psychol. 2001; 80 (3): 381–96.
Pittman CM, Karle EM. Rewire Your Anxious Brain, How to Use the Neuroscience of Fear to End Anxiety, Panic, and Worry. New Harbinger Publications Incorporated; 2014:16–24.
Гоулман Д. Эмоциональный интеллект. – М.: ACT, 2009.
Amunts K, Kedo O, Kindler M, et al. Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: intersubject variability and probability maps. Anat Embryol. 2005; 210(5–6): 343–52.
Ledoux J. The emotional brain, fear, and the amygdala. Cell Mol Neurobiol. 2003; 23(4–5): 727–38.
Tillich P, Gomes PJ. The Courage to be. New Haven [Conn.]: Yale University Press, 2000.
World Health Organization. Global health estimates 2014 summary tables: YLD estimates, 2000–2012, Available: http://www.who.int/entity/healthinfo/global_burden_disease/GHE_YLD_Global_2000_2012.xls. Accessed 8 March 2010.
Dupont RL, Rice DP, Miller LS, Shiraki SS, Rowland CR, Harwood HJ. Economic costs of anxiety disorders. Anxiety. 1996; 2(4): 167–72.
Lamers F, Van oppen P, Comijs HC, et al. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 2011; 72(3): 341–8.
Kessler RC, Berglund PA, Demler O, Jin R, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM – IV disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry.2005 Jun; 62(6): 593–602.
King, Helen (1993). "Once upon a text: Hysteria from Hippocrates". In Gilman, Sander; King; Porter, Helen; Rousseau, G.S.; Showalter, Elaine. Hysteria beyond Freud. University of California Press.
May R. The Meaning of Anxiety. W. W. Norton; 2015: 40–67.
Ibid.
Kyaga S, Landén M, Boman M, Hultman CM, Långström N, Lichtenstein P. Mental illness, suicide and creativity: 40-year prospective total population study. J Psychiatr Res. 2013 47(1): 83–90.
Silvia, P. J., & Kimbrel, N. A. (in press). A dimensional analysis of creativity and mental illness: Do anxiety and depression symptoms predict creative cognition, creative accomplishments, and creative self-concepts? Psychology of Aesthetics, Creativity, and the Arts.
Dommermuth-Costa C. Nikola Tesla, A Spark of Genius. Twenty-First Century Books; 1994: 19–21.
Jerry Bergman, Ph.D. 2004. Was Charles Darwin Psychotic? A Study of His Mental Health. Acts & Facts. 33 (1).
Panter B, Virshup B. Psychological Studies of Art and Artists. 1996.
Фрейд З. Введение в психоанализ. Лекции. – СПб.: Азбука, 2014..
Izard CE. The Psychology of Emotions. Springer; 2004. 308–12.
Klein DF. Historical aspects of anxiety. Dialogues in Clinical Neuroscience. 2002; 4(3): 295–304.
Cordain L, Eaton SB, Sebastian A, et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005; 81(2): 341–54.
Grinde B. An approach to the prevention of anxiety-related disorders based on evolutionary medicine. Prev Med. 2005; 40(6): 904–9.
Price JS. Evolutionary aspects of anxiety disorders. Dialogues in Clinical Neuroscience. 2003; 5(3): 223–236.
Читать дальше